Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

Published Apr 07 2021 at 12:00 PM GMT
Key
Points
  • BOSTON, April 07, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.
  • (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M D, Chair, President and Chief Executive Officer, will participate in a fireside chat at the 20th Annual Needham & Co.
  • Virtual Healthcare Conference on Wednesday, April 14, 2021 at 11:45 a m ET.
  • A live audio webcast of the presentation will be available u.




Stats

  • Published Apr 7, 2021 12:00 PM GMT